dwj211
Small moleculeexperimental
Clinical trial activity
3 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
1
Phase 4
0
Earliest trial started Oct 26, 2017 (NCT03224117)
Timeline
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04159961 | Phase 1 | Dec 16, 2019 | Daewoong Pharmaceutical Co. LTD. |
| NCT03946592 | Phase 3 | May 7, 2019 | Daewoong Pharmaceutical Co. LTD. |
| NCT03224117 | Phase 2 | Oct 26, 2017 | Chung-Ang University, Daewoong Pharmaceutical Co. LTD., Konkuk University, University of Ulsan |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Daewoong Pharmaceutical Co. LTD. | For profit | 3 | 3 | 3 | 2017 |
| Chung-Ang University | Academic/Hospital | 1 | 0 | 1 | 2017 |
| Konkuk University | Academic/Hospital | 1 | 0 | 1 | 2017 |
| University of Ulsan | Academic/Hospital | 1 | 0 | 1 | 2017 |
4 organizations
Page 1 / 1